These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 7693722

  • 1. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
    Figueroa JA, Sharma J, Jackson JG, McDermott MJ, Hilsenbeck SG, Yee D.
    J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
    [Abstract] [Full Text] [Related]

  • 2. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
    Arteaga CL, Osborne CK.
    Cancer Res; 1989 Nov 15; 49(22):6237-41. PubMed ID: 2553250
    [Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
    Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT, Fontana JA.
    J Cell Physiol; 1994 Jan 15; 158(1):69-78. PubMed ID: 7505280
    [Abstract] [Full Text] [Related]

  • 5. Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells.
    Yee D, Jackson JG, Kozelsky TW, Figueroa JA.
    Cell Growth Differ; 1994 Jan 15; 5(1):73-7. PubMed ID: 7510125
    [Abstract] [Full Text] [Related]

  • 6. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA, Surmacz E.
    Exp Cell Res; 1997 Feb 25; 231(1):149-62. PubMed ID: 9056422
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM, Lebwohl DE, Cullen KJ, Rubin MS, Rosen N, Mendelsohn J, Miller WH.
    J Cell Physiol; 1995 Oct 25; 165(1):212-21. PubMed ID: 7559803
    [Abstract] [Full Text] [Related]

  • 8. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells.
    van der Burg B, Isbrücker L, van Selm-Miltenburg AJ, de Laat SW, van Zoelen EJ.
    Cancer Res; 1990 Dec 15; 50(24):7770-4. PubMed ID: 2174732
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D.
    Cell Signal; 2013 Jun 15; 25(6):1395-402. PubMed ID: 23499909
    [Abstract] [Full Text] [Related]

  • 10. Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
    Kassem M, Okazaki R, De León D, Harris SA, Robinson JA, Spelsberg TC, Conover CA, Riggs BL.
    Proc Assoc Am Physicians; 1996 Mar 15; 108(2):155-64. PubMed ID: 8705735
    [Abstract] [Full Text] [Related]

  • 11. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV.
    Cancer Res; 2001 Aug 01; 61(15):5771-7. PubMed ID: 11479214
    [Abstract] [Full Text] [Related]

  • 12. Characterization and hormonal regulation of radioimmunoassayable IGF-I (insulin-like growth factor I) like activity and IGF-binding proteins secreted by human breast cancer cells.
    Ahmed SR, Manni A, Gray G, Hammond JM.
    Anticancer Res; 1990 Aug 01; 10(5A):1217-23. PubMed ID: 1700662
    [Abstract] [Full Text] [Related]

  • 13. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
    Gooch JL, Lee AV, Yee D.
    Cancer Res; 1998 Sep 15; 58(18):4199-205. PubMed ID: 9751635
    [Abstract] [Full Text] [Related]

  • 14. Cell-associated insulin-like growth factor-binding proteins inhibit insulin-like growth factor-I-induced endometrial cancer cell proliferation.
    Bermont L, Fauconnet S, Lamielle F, Adessi GL.
    Cell Mol Biol (Noisy-le-grand); 2000 Nov 15; 46(7):1173-82. PubMed ID: 11075947
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation.
    Pratt SE, Pollak MN.
    Biochem Biophys Res Commun; 1994 Jan 14; 198(1):292-7. PubMed ID: 7507320
    [Abstract] [Full Text] [Related]

  • 16. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP, Sirbasku DA.
    Cancer Res; 1988 Jul 15; 48(14):4083-92. PubMed ID: 3289739
    [Abstract] [Full Text] [Related]

  • 17. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I.
    Singh P, Dai B, Dhruva B, Widen SG.
    Cancer Res; 1994 Dec 15; 54(24):6563-70. PubMed ID: 7527300
    [Abstract] [Full Text] [Related]

  • 18. Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP, Hu XF, DeLuise M, Zalcberg JR.
    Br J Cancer; 1999 Feb 15; 79(5-6):693-700. PubMed ID: 10070856
    [Abstract] [Full Text] [Related]

  • 19. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.
    Kawamura I, Lacey E, Mizota T, Tsujimoto S, Nishigaki F, Manda T, Shimomura K.
    Anticancer Res; 1994 Feb 15; 14(2A):427-31. PubMed ID: 8017842
    [Abstract] [Full Text] [Related]

  • 20. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
    McGuire WL, Jackson JG, Figueroa JA, Shimasaki S, Powell DR, Yee D.
    J Natl Cancer Inst; 1992 Sep 02; 84(17):1336-41. PubMed ID: 1379645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.